GLUE · Company research
Monte Rosa Therapeutics, Inc. Common Stock (GLUE): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 10.17 | $1,188,318,445.95 | 1098214445.95 | 24.5238095238095238 | — | — | 132.5065171665923283 | 2.4386718258048231 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.